University of Utah · NeuroscienceNMDAR Encephalitis Research Lab
Stacey Lynn Clardy · Salt Lake City, Utah
Research Focus
Dr. Stacey Lynn Clardy's lab focuses on treating and understanding N-methyl-D-aspartate receptor (NMDAR) encephalitis, a serious autoimmune brain disorder that can cause severe psychiatric and neurological problems. The lab is conducting clinical trials to evaluate a promising treatment using inebilizumab, a monoclonal antibody that targets specific immune cells. Their research aims not only to improve patient outcomes but also to identify predictive biomarkers for treatment responses.
NMDAR encephalitisautoimmune encephalitismonoclonal antibodiesclinical trialsB-cell therapy
Research Aims
5AIM 01Evaluate the efficacy of inebilizumab in treating NMDAR encephalitis
AIM 02Assess safety outcomes of the treatment over 16 weeks
AIM 03Identify biomarkers that predict treatment responses
AIM 04Understand the role of antibody levels in disease progression
AIM 05Investigate the long-term cognitive impacts of treatment.
Skills the Lab Values
clinical trial designpatient recruitmentdata collectionneuropsychological testingbiomarker analysis
Output against the department
Publications189top 39% of dept.262nd of 671
this lab
most publishedleast published
Citations2.4kbottom 15% of dept.567th of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.